The generic drug scandal that made headlines in 1989 shocked consumers, prescribers, pharamcists, insurers, the pharmaceutical industry, the FDA and Congress. Using data collected after the scandal was reported, this study investigates the impact of scandal on pharmacists' confidence in generics, and their attitudes, opinions and behavior toward generics. Based upon the findings, the author provides a set of recommendations for marketing generic drugs.
Tijdschrift beschrijving